首页 | 本学科首页   官方微博 | 高级检索  
     

紫杉醇(泰素)治疗耐药性妇科癌症的临床报告
引用本文:蔡树模 翁仲颖. 紫杉醇(泰素)治疗耐药性妇科癌症的临床报告[J]. 肿瘤, 1995, 15(6): 444-448
作者姓名:蔡树模 翁仲颖
作者单位:上海医科大学肿瘤医院,中国福利会国际和平保健院
摘    要:紫杉醇(泰素)治疗55例耐药性妇科恶性肿瘤,每例均为对顺铂或卡铂在内的多种抗癌药耐药患者,其中半数对5种以上抗癌药耐药,近期疗效,完全缓解7例,部分缓解17例,有效率为43.6%。毒副反应主要有白细胞总数和中性粒细胞下降,超过反应有面部潮红,皮疹。脱发占100%。胃肠反应,神经毒性及心肝肾毒性均不严重。泰素对耐药卵巢癌、输卵管癌、子宫内膜癌,绒癌筹均有一定疗效,是目前治疗耐药妇癌的良好药物。

关 键 词:紫杉醇(泰素),耐药性,妇科恶性肿瘤

A CLINICAL REPORT OF DRUG-RESISTANT GYNECOLOGIC CANCER TREATED WITH PACLITAXEL
Cai Shu-mo,Tang Jie,Fan Jian-xuan et al. A CLINICAL REPORT OF DRUG-RESISTANT GYNECOLOGIC CANCER TREATED WITH PACLITAXEL[J]. Tumor, 1995, 15(6): 444-448
Authors:Cai Shu-mo  Tang Jie  Fan Jian-xuan et al
Abstract:From Sep.1993 to Dec.1994,55 cases of drug-resistant gynecologic cancer were treated with PACLITAXEL (Taxol).Complete response in 7 cases and partial response in 17 cases with a response rate of 43.6% were observed.The major toxic side effects were decrease in total white cell count and in neutrophil count.Apart from flushing of face during Taxol infusion in 12 patients and skin rash in 2 patients,the gastrointestinal,neurologic,liver and renal side effects were mild.Taxol is considered to be a drug of choice in the treatment of patients with gynecologic cancer who are resistant to conventional chemotherapy.
Keywords:Paclitaxel (Taxol)  Drug-resistant  Gynecologic cancer  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号